Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_2
2
29%
Ph not_applicable
5
71%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(3)
Terminated(1)
Other(3)

Detailed Status

unknown3
Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (28.6%)
N/A5 (71.4%)

Trials by Status

unknown343%
completed343%
terminated114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
7